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Abstract
 
The immunological basis of tuberculin-induced necrosis, known for more than a century as
“Koch’s phenomenon,” remains poorly understood. Aerosol infection in mice with the highly
virulent 
 
Mycobacterium avium
 
 strain TMC724 causes progressive pulmonary pathology strongly
resembling caseating necrosis in human patients with tuberculosis. To identify the cellular and
molecular mediators causing this pathology, we infected C57BL/6 mice and mice selectively
deficient in recombinase activating gene (RAG)-1, 
 
   
 
T cell receptor (TCR), 
 
   
 
TCR, CD4,
CD8, 
 
 
 
2-microglobulin, interferon (IFN)-
 
 
 
, interleukin (IL)-10, IL-12p35, IL-12p35/p40, or
iNOS with 
 
M. avium
 
 by aerosol and compared bacterial multiplication, histopathology, and re-
spiratory physiology in these mice. The bacterial load in the lung was similarly high in all
mouse groups. Pulmonary compliance, as a surrogate marker for granulomatous infiltrations in
the lung, deteriorated to a similar extent in all groups of mice, except in 
 
   
 
TCR-knockout
(KO) and IL-12–KO mice in which compliance was higher, and in IFN-
 
 
 
 and inducible nitric
oxide synthase–KO mice in which compliance was reduced faster. Progressive caseation of pul-
monary granulomas never occurred in 
 
   
 
TCR-KO, IL-12–KO, and IFN-
 
 
 
–KO mice and
was reduced in CD4-KO mice. In summary, 
 
   
 
TCR
 
 
 
 cells and IFN-
 
 
 
 are essential for the
development of mycobacteria-induced pulmonary caseous necrosis. In contrast, high mycobac-
terial load and extensive granulomatous infiltration per se are not sufficient to cause caseation,
nor is granuloma necrosis linked to the induction of nitric oxide.
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Introduction
 
Granuloma formation is a hallmark of mycobacterial infec-
tions and represents the histological correlate of both pro-
tective immunity and inflammatory tissue destruction (1–
3). In human tuberculosis (TB)
 
*
 
, granuloma macrophages
activated by T cells can effectively restrain the growth of
mycobacteria but may also undergo necrosis in central areas
of the granulomas (4, 5). This “caseous” center may subse-
quently liquefy and erode into a bronchus spreading 
 
Myco-
bacterium tuberculosis
 
 into the environment (6). Therefore,
granuloma necrosis and cavity formation do not only con-
tribute to the pathology in an infected individual, but are
also significantly involved in the spreading of the disease. In
addition, because antimycobacterial drugs may not suffi-
ciently penetrate into caseous lesions, curative chemother-
apy may be compromised (7). Since TB currently affects 10
million new patients each year and kills 
 
 
 
3 million of them
world-wide (8, 9), elucidation of the mechanisms that
cause this epidemiologically relevant pathology could lead
to new preventive or therapeutic strategies.
While the mediators of cellular recruitment into the
granuloma and the structural organization of the granu-
loma itself have been studied in some detail (10), no exper-
imental data are available concerning the cellular and mo-
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lecular mechanisms that mediate granuloma necrosis. This
is due to the fact that the most commonly used animal
model, the laboratory mouse, does not show granuloma
necrosis in response to aerosol infection with 
 
M. tuberculo-
sis
 
, but characteristically develops a chronic fibrosis of the
infected lung (11, 12). On the other hand, guinea pigs and
rabbits do develop caseating necrosis as a consequence of
 
M. tuberculosis
 
 infection (13–15), but most immunological
reagents, including gene-deficient strains, are not available
for these species.
We described previously an infection model in immuno-
competent mice whose pulmonary pathology strongly re-
sembles that characteristic of TB patients (16). A highly vir-
ulent strain of 
 
M. avium
 
, TMC724, when inhaled by mice
induces a progressive granulomatous response which, after
the 14th wk of infection, invariably necrotizes at the cen-
ter. Importantly, this type of necrosis differs from that ap-
parent in immunodeficient mice infected with 
 
M. tuberculo-
sis
 
, where widespread parenchymal tissue necrosis develops
(10, 17), in that a well-defined border of epithelioid mac-
rophages surrounded by perigranulomatous fibrosis seals off
the caseating center of the granuloma (16).
Here, we made use of this mouse model of mycobacte-
ria-induced pulmonary granuloma necrosis in order to in-
vestigate whether lymphocytes, and if so, which subset of
lymphocytes would be necessary to initiate this degenera-
tive event. Furthermore, we investigated the role of the
principal macrophage activating cytokine, IFN-
 
 
 
, and of
the cytokines regulating its expression, IL-10 and IL-12, in
causing granuloma necrosis, by using mouse strains selec-
tively deficient for these mediators. Since both the bacterial
load and the overall amount of inflammatory infiltration
could also be key factors, we simultaneously monitored
bacterial growth and pulmonary physiology in infected
mice over time. Our data support the view that the pres-
ence of 
 
   
 
TCR-bearing cells and the presence of IFN-
 
 
 
are essential for granuloma necrosis in this murine model of
mycobacteria-induced immunopathology. Although the
precise molecular mechanisms by which IFN-
 
 
 
 triggers
granuloma necrosis remain to be elucidated, our study rules
out a critical role for inducible nitric oxide.
 
Materials and Methods
 
Mice.
 
C57BL/6 were purchased from Charles River Labo-
ratories. The following selectively gene-deficient (knockout
[KO]
 
*
 
) mice were purchased from The Jackson Laboratory: re-
combinase activating gene (RAG)-1–KO, 
 
   
 
TCR-KO, 
 
  
 
TCR-KO, CD4-KO, CD8-KO, 
 
 
 
2-microglobulin (
 
 
 
2M)-KO,
IFN-
 
 
 
–KO, and NOS2-KO (all at least 5th generation back-
crosses to a C57BL/6 background). Mice deficient in IL-12p35,
IL-12p35/p40, or MHC class II (all at least 5th generation back-
crosses to a C57BL/6 background) were provided by H. Moss-
mann, Max-Planck-Institute for Immunobiology, Freiburg, Ger-
many. IL-10-KO mice were 10th generation backcrosses to a
C57BL/10 background, and C57BL/10 mice were used as con-
trols in experiments involving IL-10–KO mice. All mice were
free of 17 viral mouse pathogens and common bacterial or para-
sitic diseases. For the course of 
 
M. avium
 
 infection, age- and sex-
 
matched groups of mice were housed in isolator cages under bar-
rier conditions in the animal facilities at the Borstel Research
Center. All mouse experiments were approved by the Schleswig-
Holstein Ministry of the Environment, Nature and Forestation,
and an independent Institutional Review Board.
 
Bacteria. M. avium
 
 TMC724 (originally obtained from the
Trudeau Institute) was passaged in C57BL/6 mice and cultured
in Middlebrook 7H9 (Difco) medium supplemented with oleic
acid, albumin, dextrose, and catalase (Becton Dickinson) to a late
logarithmic phase. Aliquots were frozen at –70
 
 
 
C until needed.
An inoculum of bacteria was prepared by thawing several ali-
quots, washing them by centrifugation at 16,000 
 
g
 
 for 15 min,
and pooling the pellets in distilled water. Aerogenic infection was
performed in a Glas-Col aerosol infection device (Glas-Col).
Mice were exposed for 40 min to an aerosol generated by nebu-
lizing 
 
 
 
5.5 ml of a suspension containing 10
 
9
 
 CFU/ml 
 
M. avium
 
TMC724. Inoculum size (
 
 
 
10
 
5
 
 CFU/lung) was checked 24 h af-
ter infection by determining the bacterial load in the lungs of in-
fected mice. Mice were scored as moribund and killed when
weight loss was in excess of 30% compared with age-matched
uninfected controls. Groups of 4–6 mice were anaesthetized and
killed at indicated time points to follow the course of infection.
Lungs were removed aseptically and homogenized in 3 ml of dis-
tilled water to determine bacterial loads by plating serial 10-fold
dilutions of whole lung homogenates on nutrient Middlebrook
7H10 agar (Difco) supplemented with oleic acid albumin, dex-
trose, and catalase. Bacterial colony numbers (CFUS) were deter-
mined after 21-d incubation at 37
 
 
 
C in humidified air. Data for
different KO mouse strains were obtained in separate experi-
ments, each having its own control group, and are therefore pre-
sented in individual graphs. The natural course of infection and
the kinetics of granuloma formation in C57BL/6 mice infected
with 
 
M. avium
 
 TMC724 were described previously (16). There
was no difference in the kinetics of granuloma necrosis in
C57BL/6 and C57BL/10 mice.
 
Histology.
 
A 22-gauge catheter was inserted via a small inci-
sion into the trachea of anaesthetized mice and the lungs were
filled with fixative solution (4% formalin in PBS, pH 7.4) under a
hydrostatic pressure of 20–25 cm fluid column. Fixation was left
to proceed until all lung lobes were well expanded. The trachea
was clamped and the lung was removed in total and submerged in
fresh 4% formalin solution for
 
  
 
3 d, after which lungs were em-
bedded in paraffin. 3–5-
 
 
 
m sections were cut on a rotary micro-
tome (RM 2155; Leica), stretched in a water bath, and mounted
on glass slides. Sections were left to dry for 2 h at 37
 
 
 
C. Slides
were stained with standard Hematoxylin stains. Although most
experiments involving KO mouse strains were performed inde-
pendently, each with its own set of infected control C57BL/6
mice, Fig. 2 only shows one representative micrograph for
C57BL/6 mice at 19 wk after infection, because lungs of infected
C57BL/6 and C57BL/10 mice always gave the same results.
 
Isolated Ventilated and Perfused Mouse Lung.
 
The mouse lungs
were prepared and perfused at indicated time points after infec-
tion essentially as described recently (18, 19). Briefly, lungs were
perfused in a nonrecirculating fashion through the pulmonary ar-
tery at a constant flow of 1 ml/min resulting in a pulmonary ar-
tery pressure of 2–3 cm H
 
2
 
O. As a perfusion medium we used
RPMI 1640 medium lacking phenol red (Biowhittaker) at 37
 
 
 
C
and containing 4% low endotoxin grade albumin (Serva). The
lungs were ventilated by negative pressure (
 
 
 
2 cm H
 
2
 
O to 
 
 
 
10
cm H
 
2
 
O) at a rate of 90 breaths/min. Artificial thorax chamber
pressure was measured with a differential pressure transducer (DP
45–24; Validyne), and the airflow rate was measured with a 
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Fleisch-type pneumotachograph tube connected to a differential
pressure transducer (DP 45–15; Validyne). Arterial pressure was
continuously monitored by means of a pressure transducer (Isotec
Healthdyne) that was connected to the cannula ending in the
pulmonary artery. All data were transmitted to a computer and
analyzed with Pulmodyn software (Hugo Sachs Elektronik). Tidal
volume (V
 
T
 
) was derived by integration of the flow rate, and the
data were analyzed by applying the formula: P 
 
 
 
 1/C·V
 
T
 
 
 
 
 
R
 
L
 
·dV
 
T
 
/dt, where P is chamber pressure, C is pulmonary com-
pliance, and R
 
L
 
 lung resistance. All compliance data shown were
obtained after 20 min of perfusion and ventilation.
 
Statistics.
 
Quantifiable data (CFU counts, pulmonary compli-
ance) were analyzed using Student’s 
 
t
 
 test. For multiple compari-
sons, one-way ANOVA and Tukey’s posttest were used. Means,
SDs, confidence intervals, and statistics were calculated using
GraphPad Prism version 3.00 for Windows (GraphPad Software,
San Diego, CA; www.graphpad.com).
 
Results
 
Histopathology, Bacterial Load, and Pulmonary Compliance in
C57BL/6 Mice Aerogenically Infected With M. avium.
 
Af-
ter aerosol infection with 10
 
5
 
 CFU 
 
M. avium
 
 TMC724,
there was progressive growth of the organism until a pla-
teau was reached at 
 
 
 
10
 
10
 
 CFU per lung (Fig. 1 A). Start-
ing around week 14 after infection, mice exhibited signs of
dyspnea and hyperventilation, and appeared moribund by
 
 
 
20 wk after infection.
Using isolated and perfused mouse lungs of infected ani-
mals we measured pulmonary compliance to establish an
independent parameter reflecting alveolar and interstitial
space occupied by inflammatory infiltrations. Data obtained
at various time points in a typical experiment are shown in
Fig. 1 B. Pulmonary compliance deteriorated progressively
in infected mice, dropping below 10 
 
 
 
l/cm H
 
2
 
O at around
14 wk after infection and falling as low as 5 
 
 
 
l/cm H
 
2
 
O
when mice became moribund. In contrast, uninfected con-
trol mice showed a slight increase in their pulmonary com-
pliance as they grew older, which was generally in the same
range as reported before (18). Fig. 1 C summarizes data
from a total of six experiments showing all individual mea-
surements and the 95% confidence interval of data points
taken during two late time points of infection. Although
there was some variability in individual mice, it is evident
that respiratory insufficiency was the likely cause of death
in infected mice.
After aerosol infection, a distinct pattern of progressive
pulmonary pathology developed, as described previously
(16). At 
 
 
 
10 wk after infection, there was widespread infil-
tration of alveolar and interstitial space with epithelioid and
foamy macrophages, occupying up to one-half of the lung.
Most of these macrophages showed signs of being activated
because they stained positive for inducible nitric oxide syn-
thase (iNOS; data not shown). Lymphocytes were apparent
in aggregated form, located for the most part on the pe-
riphery of these massive infiltrations. At 
 
 
 
14 wk after in-
fection, granulomatous infiltrations further coalesced, and
first signs of irreversible cell damage appeared, such as con-
densation of nuclei and small foci of nuclear debris within
macrophage-rich areas. Finally, 2–3 wk before animals
were killed due to their deteriorating general condition,
full-blown caseating necrosis was evident in the majority of
granulomatous lesions of the lung of all mice (Fig. 2 A and
B). Caseous necrosis uniformly occurred at the center of
the granulomas which had been occupied previously by
heavily infected macrophages (15). Caseous centers were
surrounded by a variably thick zone of degenerating neu-
trophils, which in turn was demarcated from the remaining
lung tissue by a wide layer of macrophages that appeared,
by light-microcospic criteria, as epithelioid (insert in Fig. 2
Figure 1. Course of aerosol infection with M. avium in immunocom-
petent mice C57BL/6 mice were infected with  105 CFU M. avium
TMC724 by aerosol. (A) Bacterial growth was followed in lungs over
time (mean CFU of six mice per group   SD). (B) Pulmonary compli-
ance was measured in uninfected (white squares) and infected mice (black
squares) over time (means of three mice per group   SD). C shows a
compilation of individual compliance measurements from a total of six
experiments (white squares, uninfected mice at 14 and 19 wk after infec-
tion; black squares, aerosol-infected mice at 14 and 19 wk after infection).
The shaded areas represent the 95% confidence interval of all data col-
lected at the indicated time point. 
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B). For the comparison of histological sections described
below, we chose the time point at 19 wk after infection.
Since progressive lesion development strongly correlated
with progressively deteriorating compliance in infected
mice, it appeared feasible to use impairment of respiratory
function measured by compliance as a quantitative surro-
gate parameter for increasing infiltration of total lung space.
 
Granulomatous Lesions in C57BL/6 and RAG-1–KO, 
 
  
 
TCR-KO, 
 
  
 
TCR-KO, CD4-KO, CD8-KO, 
 
 
 
2M-KO,
and MHC Class II-KO Mice Aerogenically Infected with M.
avium.
 
First, we wished to establish whether specific lym-
phocytes were involved in granuloma necrosis after 
 
M.
avium
 
 infection. When RAG-1–KO mice deficient in B
and T lymphocytes were infected, caseation did not occur
at any time point examined. In moribund mice at 19 wk
after infection there were a few necrotic cells, isolated or in
groups, scattered throughout the extensive sheets of foamy
and epithelioid macrophages, but the characteristic feature
of large, well-demarcated centrally caseating lesions present
in immunocompetent mice was never apparent (Fig. 2 A
and B versus C and D). Thus, caseous granuloma necrosis
depends on the presence of specific lymphocytes.
Next, we wished to determine whether T cells and
which T cell subset might be responsible for the induction
of granuloma necrosis. When mice deficient for either the
 
   
 
TCR or the 
 
   
 
TCR were infected, it became evident
that only mice bearing the 
 
   
 
TCR were capable of devel-
oping caseous necrosis (Fig. 2 A and B). At 19 wk after
infection, 
 
   
 
TCR-KO mice had a few necrotic cells
scattered over the entire lung, but never showed the
pathognomonic structure of centrally caseating granulomas
(Fig. 2 E and F). In contrast, 
 
   
 
TCR-KO mice were no
different from immunocompetent mice regarding the ex-
tent and morphological aspect of granuloma necrosis (Fig. 2
G and H).
Next, we examined pulmonary pathology in mice defi-
cient for individual T cell subsets. Most CD4-deficient
mice exhibited only few “pockets” of dead or dying cells
dispersed throughout the granulomatous infiltrations (Fig. 2
K). Some moribund mice deficient for CD4 also showed
incipient necrotic foci at the centers of epithelioid macro-
phage agglomerations, but these were never as prominent
in size and as typically organized as in C57BL/6 mice (Fig.
2 I). When the experiment was repeated, an additional
Figure 2. Histopathology of lungs from immunocompetent and T cell subset–deficient mice at 19 wk infection with M. avium. Mice were infected
with  105 CFU M. avium TMC724 by aerosol, and lungs from infected mice were removed at 19 wk after infection and processed for H&E staining.
Low-power micrographs shown are representative of at least three mice per group (A, C, E, G, I, L, and N, original magnifications:  12; B, D, F, H, K,
M, and O, original magnifications:  32; insert in B, original magnification:  320). (A and B) C57BL/6 mice. (C and D) RAG-1–KO. (E and F)   
TCR-KO mice. (G and H)    TCR-KO mice. (I and K) CD4-KO mice. (L and M) CD8-KO mice. (N and O)  2M-KO mice.1851 Ehlers et al.
group of MHC class II–deficient mice was also examined.
These mice showed no signs at all of necrosis within the
extensive sheets of epitheliod macrophages infiltrating the
lung at 19 wk after infection (data not shown). CD8-defi-
cient and  2M-KO mice developed granuloma necrosis to
the same extent and with a similar appearance as infected
wild-type mice (Fig. 2 L–O). In summary, the major con-
tributor to central granuloma necrosis within the    TCR-
bearing subset is in the MHC class II–restricted CD4  T
cell compartment.
Bacterial Load and Compliance in the Lungs of C57BL/6 and
RAG-1–KO,    TCR-KO,    TCR-KO, CD4-KO, and
CD8-KO Mice Aerogenically Infected with M. avium. The
failure to develop central caseation in RAG-1–KO,   
TCR-KO and, to a large extent, in CD4-KO mice, could
be a result of different bacterial loads in the lungs of these
mice, or of altered kinetics or extent of inflammatory cell
infiltration. However, there was no difference between
RAG-1–KO and C57BL/6 mice in terms of CFU counts
in either lung (Fig. 3 A), liver or spleen (data not shown) at
both 14 and 19 wk after infection.    TCR-KO mice did
have higher CFU counts in their lungs at 14 wk after infec-
tion, but this was no longer statistically significant at 19 wk
after infection when histopathology was compared (Fig. 3
B). CD4-KO, CD8-KO, and  2M-KO mice showed the
same bacterial load as control C57BL/6 mice when exam-
ined at either 14 or 19 wk after infection (Fig. 3 C). There-
fore, high mycobacterial load per se is not correlated with
onset of granuloma necrosis.
Concerning overall diminution of pulmonary elasticity
due to inflammatory cell influx, there was a tendency in
RAG-1–KO mice to have a slightly better pulmonary
compliance at 14 wk after infection, but this was not statis-
tically significant (Fig. 4 A). Likewise,    TCR-KO mice
had a less severe reduction in pulmonary compliance, start-
Figure 3. Bacterial loads in immunocompetent and T cell subset–defi-
cient mice after aerosol infection with M. avium. Mice were infected with
 105 CFU M. avium TMC724 by aerosol, and bacterial growth was de-
termined in the lungs at indicated time points after infection. Data are the
mean CFU   SD of 4–6 mice per time point. (A) C57BL/6 mice (black
bars), RAG-1–KO mice (white bars). (B) C57BL/6 mice (black bars),   
TCR-KO mice (white bars),   TCR-KO mice (gray bars). (C) C57BL/6
mice (black bars), CD4-KO mice (white bars), CD8-KO mice (light gray
bars),  2M-KO mice (dark gray bars). *P   0.05 vs. C57BL/6.
Figure 4. Pulmonary compliance in immunocompetent and T cell
subset–deficient mice after aerosol infection with M. avium. Mice were
infected with  105 CFU M. avium TMC724 by aerosol, and pulmonary
compliance was determined in the isolated and perfused mouse lungs at
indicated time points after infection. For purposes of interassay data com-
parability, the horizontal areas shaded in dark gray represent the 95% con-
fidence interval of measurements from six independent experiments in
uninfected mice (Fig. 1 C), and the horizontal areas shaded in light gray
represent the 95% confidence interval of measurements taken in infected
C57BL/6 mice from six independent experiments (Fig. 1 C). (A)
C57BL/6 mice (black bars), RAG-1–KO mice (white bars). (B) C57BL/6
mice (black bars),    TCR-KO mice (white bars),    TCR-KO mice
(gray bars). (C) C57BL/6 mice (black bars), CD4-KO mice (white bars),
CD8-KO mice (light gray bars),  2M-KO mice (dark gray bars). Data are
the means   SD of 3–6 mice per group. *P   0.05 vs. C57BL/6 and   
TCR-KO mice.1852 Immunological Mechanisms of Mycobacteria-induced Granuloma Necrosis
ing at 14 wk after infection, and reaching statistical signifi-
cance at 19 wk after infection (Fig. 4 B). CD4-KO, CD8-
KO, and  2M-KO mice had similar loss of pulmonary
elasticity at 14 and 19 wk after infection as infected
C57BL/6 mice (Fig. 4 C). At 19 wk after infection, when
granuloma necrosis was compared histologically, there was
no difference in pulmonary compliance between any of the
different KO-mouse strains (with the exception of   
TCR-KO mice) and simultaneously infected C57BL/6
mice (Fig. 4 A–C). In summary, the development of
caseous necrosis in immunocompetent mice as opposed to
RAG-1–KO or CD4-KO mice is not related to differen-
tially altered pulmonary compliance in these mice.
Granulomatous Lesions in C57BL/6 and IFN- –KO, IL-
10–KO, IL-12p35-KO, IL-12p35/p40-KO, and iNOS-KO
Mice Aerogenically Infected with M. avium. Determination
of cytokine mRNA levels in lung homogenates from
C57BL/6, RAG-1–KO, and    TCR-KO mice aerogeni-
cally infected with M. avium revealed that KO mice consis-
tently had  10-fold lower levels of IFN-  mRNA in
lesion-harboring lungs than wild-type mice (data not
shown). Therefore, we wished to establish whether IFN- 
was causally involved in granuloma necrosis. In a typical
aerosol infection with M. avium, IFN- –KO mice started
to become moribund as early as day 70 after infection, and
all IFN- –KO mice were dead by 15 wk after infection
(Fig. 5). When histopathology was examined, there was
advanced leukocyte infiltration already at 10 and 14 wk af-
ter infection. Infiltrations in IFN- –KO mice appeared
highly disorganized and of mixed cellularity with a high
proportion of neutrophils (insert in Fig. 6 D). Despite this
excessive cellular influx, caseation did not occur at any time
point examined in IFN- –KO mice. When the experi-
ment was repeated, three IFN- –KO mice survived until
week 19 after infection, but again showed no signs of
caseating necrosis despite massive pulmonary granulocyte
infiltration (Fig. 6 C and D).
Since the expression of IFN-  is regulated by both IL-12
and IL-10, we next determined whether the absence of
Figure 5. Survival of various cytokine- or iNOS-deficient mouse
strains after aerosol infection with M. avium. Mice were infected with
 105 CFU M. avium TMC724 by aerosol, and moribund mice were
killed. Data shown are the percentage of surviving mice, the total number
of mice per group ranging from 12 to 16.
Figure 6. Histopathology of lungs from immunocompetent and cytokine-
or iNOS-deficient mice at 19 wk after infection with M. avium. Mice were
infected with  105 CFU M. avium TMC724 by aerosol, and lungs from in-
fected mice were removed at 19 wk after infection and processed for H&E
staining. Micrographs shown are representative of at least three mice per
group (A, C, E, G, I, and L, original magnifications:  12; B, D, F, H, K,
and M, original magnifications:  32; insert in D, original magnification:
 20). (A and B) C57BL/6 mice. (C and D) IFN- –KO mice. (E and F)
IL-12p35-KO mice. (G and H) IL-12p35/p40-KO mice. (I and K) IL-10–KO
mice. (L and M) iNOS-KO mice.1853 Ehlers et al.
these cytokines would also impact on granuloma necrosis
after aerosol M. avium infection. Gene-targeted mouse
strains, lacking either only p35 or both the p35 and the p40
component of IL-12, survived the entire 20-wk examina-
tion period (Fig. 5). In both strains, there was extensive
granulomatous infiltration composed almost exclusively of
epithelioid cells, but caseous necrosis was conspicuously
absent (Fig. 6 E–H). In contrast, IL-10–KO mice showed
advanced signs of granuloma necrosis as early as 14 wk after
infection and exhibited marked central caseation of granu-
lomatous lesions at 19 wk after infection, similar to infected
wild-type controls (Fig. 6 I and K).
Since nitric oxide is a known effector of both inflamma-
tory and antibacterial responses induced by IFN- , mice
deficient for iNOS-KO were also infected with M. avium
via aerosol. Infected iNOS-KO mice became moribund in
a similar time frame as infected IFN- –KO mice (Fig. 5).
Although granuloma necrosis appeared to occur less fre-
quently and in a somewhat delayed fashion, it was clear that
massive central necrotization of epithelioid granulomas was
present in surviving mice at 19 wk after infection (Fig. 6 L
and M).
In summary, IFN-  is necessary for granuloma necrosis
in this murine model of mycobacteria-induced immunopa-
thology, but the mechanism of necrotization is indepen-
dent of iNOS.
Bacterial Load and Compliance in the Lungs of C57BL/6 and
IFN- –KO, IL-10–KO, IL-12p35-KO, IL-12p35/p40-KO,
and iNOS-KO Mice Aerogenically Infected with M. avium.
The failure to develop central caseation in IFN- –KO and
IL-12–KO mice could be a result of different bacterial
loads in the lungs of these mice, or of altered kinetics or
extent of inflammatory cell infiltration. However, there
was no significant difference between IL-12p35-KO, IL-
12p35/p40-KO, and C57BL/6 mice in terms of CFU
counts in either lung (Fig. 7 B), liver, or spleen (data not
shown) at both 14 and 19 wk after infection. IL-10–KO
mice also had comparable bacterial loads in these organs
(Fig. 7 C). IFN- -KO mice had significantly higher CFU
counts in their lungs at 10 wk (data not shown) and 14 wk
after infection. (Fig. 7 A). In contrast, iNOS-KO mice had
significantly lower bacterial counts in their lungs at 14 and
19 wk after infection. (Fig. 7 D), corroborating the inter-
pretation that high mycobacterial load per se is not corre-
lated with onset of granuloma necrosis.
Although there was a tendency for IL-12p35/p40-KO
mice to have a better compliance than IL-12p40 produc-
ing IL-12p35-K0 mice at 14 wk after infection, this was
not statistically significant. Both IL-12–deficient strains,
lacking either only p35 or both p35/p40 chains of IL-12,
had a profoundly better pulmonary compliance at 19 wk
after infection than infected wild-type mice (Fig. 8 B). IL-
10–KO mice had a similar loss of pulmonary elasticity at
14 and 19 wk after infection as infected syngenic wild-
type mice (Fig. 8 C). In contrast, both IFN- -KO and
iNOS-KO mice had dramatically reduced pulmonary elas-
ticity already at 14 wk after infection, and respiratory in-
sufficiency became incompatible with life before 19 wk af-
ter infection in most of these mice (Fig. 8 A and D). In
summary, the absence of caseous necrosis in IL-12-KO or
IFN- –KO mice (as opposed to immunocompetent mice)
is not directly correlated with altered pulmonary compli-
ance in these immunodeficient mice, whereas early death
of IFN- –KO and iNOS-KO mice can be explained by
advanced pulmonary insufficiency.
Discussion
Robert Koch was the first to describe the phenomenon
in guinea pigs that  6 wk after establishment of infection
Figure 7. Bacterial loads in immunocompetent
and cytokine- or iNOS-deficient mice after aerosol
infection with M. avium. Mice were infected with
 105 CFU M. avium TMC724 by aerosol, and
bacterial growth was determined in the lungs at in-
dicated time points after infection. Data are the
mean CFU   SD of 4–6 mice per time point. (A)
C57BL/6 mice (black bars), IFN- –KO mice
(white bars), ND, not determined due to prema-
ture death of mice. (B) C57BL/6 mice (black bars),
IL-12p35-KO mice (gray bars), IL-12p35/p40-KO
mice (white bars). (C) C57BL/10 mice (black bars),
IL-10–KO mice (white bars). (D) C57BL/6 mice
(black bars), iNOS-KO mice (white bars). *P  
0.05 vs. C57BL/6.1854 Immunological Mechanisms of Mycobacteria-induced Granuloma Necrosis
with M. tuberculosis, intradermal challenge with whole or-
ganisms results in necrosis both at the site of injection and
in the original tuberculous lesion (20, 21). These poten-
tially harmful effects of specific delayed-type hypersensi-
tivity (DTH) and, more particularly, their relationship to
cell-mediated protective immunity capable of containing
growth of M. tuberculosis have been the subject of consid-
erable debate and confusion (1, 6, 22, 23). In essence,
however, the cellular and molecular mediators responsible
for this type of necrosis have thus far defied experimental
definition. This is largely due to the lack of an animal
model which would adequately reflect the mycobacteria-
induced immunopathology present in human TB patients,
i.e., caseating granuloma necrosis, and, at the same time,
permit selective manipulation of isolated components of
the immune system.
Using selectively gene-deficient mice in a model system
which strongly resembles human pathology, we now un-
equivocally show that    TCR-bearing cells, but not   
TCR-bearing cells, are necessary for granuloma necrosis,
and that this degenerative event is predominantly ac-
counted for by the MHC class II–restricted CD4 , but not
the CD8  T cell subset. In addition, we show that IFN-  is
necessary for granuloma necrosis to occur, but that IFN- 
does not mediate necrotization by inducing nitric oxide.
We further provide evidence that neither bacterial load, nor
the overall amount of inflammatory infiltration per se are
ultimately decisive for granuloma caseation. On the other
hand, the death of infected mice, particularly the premature
death in mice with a deficiency for IFN-  or iNOS, does
not correlate with the onset of granuloma necrosis, but is
more closely associated with the extent of respiratory dis-
tress due to excessive inflammatory infiltrates in these mice.
Some unique features of the model system used contrib-
uted to the findings detailed in this report. The first con-
cerns the choice of organism used for infection. M. avium is
an opportunistic pathogen in humans mostly affecting pa-
tients with a local or systemic immunodeficiency (24). In
immunocompetent children and adults, however, it some-
times leads to a clinico-pathological presentation not dis-
similar to TB (25). In mice, the causative organism of TB,
M. tuberculosis, causes chronic fibrosis (11, 26), whereas,
fortuitously, M. avium infection induces a pathology highly
similar to that found in human TB (16, 27). It is obvious
that protection and immunity can best be studied in model
systems using the causative organism itself (28, 29). How-
ever, the mechanisms involved in the immunopathology of
TB may only be accessible, at least in the mouse, in an in-
fection model mimicking the pathology of human TB.
Because TMC724 is so virulent already in immunocom-
petent mice and because select immunodeficiencies hardly
affect its growth rate in vivo, another common confound-
ing factor when examining the course of infection in KO
mouse models, i.e., differential bacterial growth, is of little
relevance in this model. This latter feature has enabled us to
determine that high bacterial load is not sufficient to induce
granuloma necrosis, since IFN- –KO and    TCR-KO
mice had the highest bacterial counts in their organs, yet
showed no signs of centrally necrotizing granulomas. On
the other hand, M. avium-infected iNOS-KO mice exhib-
ited significantly lower CFU counts in the lungs, as was re-
ported previously for the liver and spleen after intravenous
infection with this M. avium strain in these mice (30).
However, iNOS-KO mice aerogenically infected with M.
avium did develop granuloma necrosis, albeit to a slightly
lesser extent than infected wild-type control mice. That the
Figure 8. Pulmonary compliance in
immunocompetent and cytokine- or
iNOS-deficient mice after aerosol infec-
tion with M. avium. Mice were infected
with  105 CFU M. avium TMC724 by
aerosol, and pulmonary compliance was
determined in the isolated and perfused
mouse lungs at indicated time points af-
ter infection. For purposes of inter-assay
data comparability, the horizontal areas
shaded in dark gray represent the 95%
confidence interval of measurements
from six independent experiments in un-
infected mice (Fig. 1 C), and the hori-
zontal areas shaded in light gray represent
the 95% confidence interval of measurements
taken in infected C57BL/6 mice from six
independent experiments (Fig. 1 C). (A)
C57BL/6 mice (black bars), IFN- –KO mice
(white bars), ND, not determined due to pre-
mature death of mice. (B) C57BL/6 mice
(black bars), IL-12p35-KO mice (gray bars),
IL-12p35/p40-KO mice (white bars). (C)
C57BL/10 mice (black bars), IL-10–KO mice
(white bars). (D) C57BL/6 mice (black bars),
iNOS-KO mice (white bars). Data are the
means   SD of three mice per group. *P  
0.05 vs. C57BL/6 mice.1855 Ehlers et al.
overall quantity of bacterial CFU has some role in inducing
necrosis, is evident from infection experiments with less
virulent strains of M. avium, that do not reach the excessive
levels of bacterial replication as does TMC724, in which
central granuloma necrosis did not occur (16, 27). Our re-
sults, however, clearly rule out the existence of a mycobac-
teria-derived factor directly inducing this organized form of
tissue damage.
A novel feature of our experimental system is the use of
pulmonary compliance as an independent quantitative pa-
rameter for loss of recruitable lung space and/or interstitial
elasticity in the course of infection. This parameter has al-
lowed us to objectively compare different groups of KO
mice at different stages of infection because their functional
respiratory parameters were essentially identical. For in-
stance, although pulmonary compliance was similarly low
in wild-type, RAG-1–KO and IL-10–KO mice at 19 wk
after infection, histopathology was grossly different; granu-
loma necrosis was completely absent in RAG-1–KO mice,
but accelerated in IL-10–KO mice compared with wild-
type mice. IL-12–deficient and    TCR-KO mice also
exhibited no centrally necrotizing granulomas. However,
these mice had a significantly better pulmonary compli-
ance, likely due to the fact that IL-12 and    TCR  cells
are also involved in accelerating inflammation. Therefore,
delayed recruitment of inflammatory cells into the lung
may be one factor contributing to the lack of granuloma
necrosis in    TCR- or IL-12–deficient mice. With regard
to the differences in pulmonary compliance between
RAG-1–KO and    TCR-KO mice, it is possible that un-
balancing of a subtle cross-regulation of the    TCR  and
the    TCR  subsets is most evident when only one T cell
subset, but not both, is missing.
Our histopathological results with    TCR-KO mice
are difficult to reconcile with the findings published by
Saunders et al. who reported that     TCR-KO mice
never developed centrally caseating lesions in response to
pulmonary M. avium infection (27). However, these inves-
tigators used a much lower dose of infection (500 CFU/
mouse) and examined lung histopathology at relatively
early time points (days 90 and 120 after infection). Our
own data fit very well with the previously documented an-
tiinflammatory role of     TCR-bearing cells in other
model systems. For example,   TCR  cells regulate and
harness    TCR bearing cells in Listeria monocytogenes in-
fection, where the absence of    TCR  cells results in ac-
celerated and enhanced pyogenic necrosis of granuloma-
tous lesions (31, 32). Similarly, M. tuberculosis infection in
  TCR-KO mice leads to increased neutrophil influx into
granulomas (33).
We found that some CD4-deficient mice had a few
small necrotic foci at the centers of granulomatous lesions
suggesting that a subset of    TCR  cells negative for the
CD4 marker might be capable of inducing caseation. One
subset of    TCR  cells which is negative for both the
CD4 and the CD8 markers has indeed been implicated
in the killing of mycobacteria-infected target cells and
also of mycobacteria themselves (34). These    TCR 
CD4 CD8  cells utilize CD1 as their major restricting ele-
ment during antigen presentation (35, 36). However, when
 2M-KO mice known to be deficient not only in MHC
class I, but also in CD1, were infected with M. avium by
aerosol, they showed no difference in either the kinetics or
the extent of granuloma necrosis when compared with
wild-type mice. Therefore, it appears reasonable to assume
that, as previously demonstrated in CD4-deficient mice in-
fected with Leishmania major or M. tuberculosis (37, 38), a
numerically significant amount of “unusual”, compensatory
MHC class II–restricted CD4 CD8  T cells still exist in
these mice that are functional in the same way as CD4 
cells in terms of cytokine secretion and, potentially, mem-
brane-dependent events that may ultimately lead to granu-
loma necrosis. This hypothesis was corroborated by our ex-
periments in MHC class II-KO mice which had no signs of
granuloma necrosis at 19 wk after infection with airborne
M. avium.
In the search for a mechanism by which    TCR-bear-
ing cells would mediate granuloma necrosis we identified
IFN-  as a critical factor. IFN-  is the major inducer of an-
tibacterial effector functions in mycobacteria-infected mac-
rophages, and also plays a significant role in the formation
of organized granulomas in response to mycobacterial in-
fections (39–41). In other model systems, such as autoim-
mune encephalomyelitis, the absence of IFN-  causes a
highly disorganized, hyperinflammatory response charac-
terized by the increased influx of CD4  T cells and granu-
locytes (42, 43). Moreover, infection with mycobacteria
was documented previously to cause a severe hematopoi-
etic remodelling in IFN- –KO mice, resulting in ex-
tramedullary hematopoiesis and marked granulocytosis in
the peripheral blood (44). IFN-  has been shown to induce
apoptosis of activated T cells, thereby limiting the inflam-
matory response, in other experimental systems including
that of pulmonary infection with M. tuberculosis (43, 45).
Although not directly investigated here, the absence of this
mechanism may have contributed to the hyperinflamma-
tory response seen here in the absence of IFN- .
Our results from infected IL-10– and IL-12–deficient
animals are in line with current thinking about the regula-
tion of IFN-  production. Thus, IL-10 downregulates
IFN-  secretion in vitro and in vivo (46), and the acceler-
ated granuloma necrosis we observed in IL-10–deficient
mice may be interpreted as a consequence of increased
IFN-  levels in these mice. Aggravated immunopathology
has been observed by other investigators examining au-
toimmune diseases (47, 48) or intracellular infections (49)
in IL-10–KO mice (50), and has generally been attributed
to the increased production of IFN-  in these mice (51).
In a mouse model of intravenous infection with Crypto-
coccus neoformans, the development of granulomas was abol-
ished in IL-12p40-KO mice, but not reduced when IL-
12p40 was still present in IL-12p35-KO mice (52). When
we infected the same strains of KO mice with M. avium by
aerosol, we found that pulmonary granuloma necrosis was
completely absent, but that there was no difference be-
tween mice lacking only p35 or both, p35 and p40 chains1856 Immunological Mechanisms of Mycobacteria-induced Granuloma Necrosis
of IL-12 at the time points studied. In contrast to IFN- –
KO mice, however, inflammation was significantly re-
duced, rather than exacerbated, as evidenced by increased
pulmonary compliance in both IL-12p35-KO and IL-
12p35/p40-double-KO mice at week 19.
When interpreting these seemingly paradoxical results
in infected IL-12–KO and IFN- –KO mice, it should be
kept in mind that not all effects of IL-12 are mediated by
IFN-  (53). For instance, when IFN- R–KO mice were
treated with recombinant IL-12, they developed extensive
pulmonary macrophage infiltrations and died from diffuse
pulmonary edema (54). Conversely, in parallel experi-
ments done in an intravenous model of M. avium infec-
tion, we observed that IFN-  is not entirely absent in in-
fected tissues of IL-12–KO mice (unpublished data).
Although we did not investigate IFN-  levels in the lungs
of IL-12–KO mice in the studies presented here, we hy-
pothesize that residual, but significantly above-background
levels of IFN-  that are induced even in the absence of IL-
12 are sufficient to prevent the highly dysregulated inflam-
matory response seen in the complete absence of IFN-  in
IFN- –KO mice, but are much too low to induce recruit-
ment and activation of inflammatory cells to the level ob-
served in wild-type mice.
One important effector mechanism triggered by IFN- 
is the induction of nitric oxide in macrophages (55). Nitric
oxide does not inhibit growth of M. avium as it does with
M. tuberculosis (30, 56), but nitric oxide is involved in the
downregulation of the inflammatory response to M. avium
(57). Nitrogen intermediates and their reaction products
can be highly toxic to both tumor and parenchymal cells
(55), and we reasoned that granuloma necrosis induced by
IFN-  might be mediated by the tissue-destroying sequelae
of NO production in our model. However, results from
our experiments with iNOS-KO mice unequivocally show
that granuloma necrosis in this model occurs independently
of iNOS, although the overall inflammatory dysregulation
evident in iNOS-KO mice, with dramatically reduced pul-
monary function and premature death of infected mice,
was similar to that seen in IFN- –KO mice.
These convergent and divergent effects of IFN-  and
iNOS on the overall inflammatory response and the induc-
tion of granuloma necrosis may best be explained as fol-
lows: IFN-  modulates a number of quantitative and
qualitative aspects of inflammation, such as endothelial
molecule expression, vascular leakiness, and leukocyte ex-
travasation, via the induction of nitric oxide (57–59). In
addition, during mycobacterial infections, IFN- –induced
nitric oxide may suppress T cell functions and induce
apoptosis of CD4  T cells thereby controlling excess in-
flammation (45, 60, 61).
The mechanisms induced by IFN-  that cause the ne-
crotization of granulomas, however, are clearly distinct
from nitric oxide. It is at present unclear whether IFN- 
directly acts on macrophages at the center of the granuloma
causing them to necrotize, or whether IFN-  induces
other mediators which in turn cause necrosis. IFN-  is
known to induce several chemokines, and it is intriguing
that some of them, such as IFN- -inducible protein of 10-
kD (IP)-10, monokine induced by IFN-  (Mig), IFN-
inducible T cell   chemoattractant (I-TAC), and secondary
lymphoid tissue chemokine (SLC), have profound angio-
static properties (62). It is conceivable that chemokine-
mediated reduced vascularization and concomitant hypoxia
of granulomas are the ultimate downstream events respon-
sible for caseous necrosis. A similar scenario was recently
described for tumor regression during acute Toxoplasma
gondii infection in mice (63).
Finally, it is worth mentioning that we cannot at present
exclude that TNF is also involved in the process of granu-
loma necrotization. TNF is thought to sensitize infected
cells for subsequent necrosis and has been a prime candidate
for explaining the Koch phenomenon (22, 64). However,
after  M. avium infection of TNF receptor of 55 kD
(TNFRp55)-KO mice by either the aerogenic or the intra-
venous route, granuloma formation and maintenance are
severely impaired very early during infection, and all
TNFRp55-KO mice succumb to infection at the same
time that granulomas disintegrate (16, 65). Therefore, the
role of TNF in granuloma necrosis could not be appropri-
ately addressed in this model.
Dannenberg and Rook used the term “tissue-damaging
DTH” for the immune response leading to pathology, i.e.,
necrotizing lesions, and reserved the term “cell-mediated
immunity” for the macrophage-activating immune re-
sponse leading to bacteriostasis in the course of infection
with M. tuberculosis (6). The interplay and ratio between
these two phenomena remain unknown. Indeed, caseous
necrosis and tissue damage may merely be an excess of cell-
mediated immunity, or represent an extreme form of pro-
tection, as it is clear that mycobacteria do not thrive in
caseous lesions (66). It seems a reasonable approach to use
the aerosol M. avium model system to determine the mo-
lecular mediators of tissue damage, and subsequently verify
that similar mechanisms are operative in M. tuberculosis le-
sions in human patients. However, extrapolation of our re-
sults to protective immunity to TB is not readily possible,
because the mechanisms of killing M. avium are likely very
different from those involved in killing M. tuberculosis (28,
30, 56). For this reason, an animal model reflecting human
pathology, but using M. tuberculosis itself, will be very im-
portant. In this regard, it was recently reported that iNOS-
KO mice aerogenically infected with M. tuberculosis devel-
oped lesions similar to those described here (67). One
might therefore speculate that very low levels of nitric ox-
ide, such as those presumably present in human lungs, may
actually favor the development of caseating necrosis in re-
sponse to M. tuberculosis infection.
From experience with human TB patients, it is well-
known that a severe deficiency in the T cell compartment
precludes a positive intradermal DTH reaction to tubercu-
lin (68, 69). Moreover, AIDS patients suffering from ad-
vanced deficiency in the CD4  T cell compartment and
patients having defects in the IL-12/IFN-  signaling path-
ways fail to develop circumscript granulomas and never ex-
hibit extensive caseating necrosis and/or cavitation after M.1857 Ehlers et al.
tuberculosis or M. avium infection, but rather develop dis-
seminated disease (70–77). In contrast, AIDS patients with
residual disseminated M. avium infection develop necrotiz-
ing granulomas under antiretroviral therapy as soon as their
CD4  cell number and response is restored (78–80). We
take this as evidence that our experimental system in mice
is valid in that it reflects at least some processes occurring
also in humans infected with mycobacteria. Taking advan-
tage of the ready availability of mouse strains with targeted
mutations in candidate molecules, this model can now be
employed to define the mediators of granuloma caseation
that lie downstream from IFN- . This approach may ulti-
mately lead to novel adjuvant therapeutic strategies aimed
at inhibiting caseation and liquefaction of the granuloma in
order to facilitate antimicrobial chemotherapy and reduce
the spread of microorganisms.
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